• Home
• About Us
• Events
• Editorials
• Recent Contributions
• CMReJournal

• CMR Short Reviews
  • The Concept of CMR

    Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.

    • Definition and History
    • The Obesity and Type 2 Diabetes Epidemics
    • Epidemiology
    • Intra-abdominal Adipose Tissue: the Culprit?
    • Intra-abdominal Obesity and Cardiometabolic Risk
  • Evaluating CMR

    Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).

    • Clinical Tools
    • Imaging Techniques
    • Assessing CVD Risk: Traditional Approaches
    • Metabolic Syndrome and Type 2 Diabetes/CVD Risk
    • Assessing Cardiometabolic Risk
  • Managing CMR

    Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.

    • Targeting Traditional CVD Risk Factors in Patients With Abdominal Obesity
    • Residual Cardiometabolic Risk of Treated Patients
    • Effects of Weight Loss on Adipose Tissue Distribution
    • Managing CMR in Abdominally Obese Patients
    • Preventing Type 2 Diabetes
• Documentation Centre
  •  Slides, videos and more
    • Slide Library
    • Expert Opinions
    • Webcasts
    • Key Publications
    • Image Base
    • Advanced Search

• Home
• About Us
• Executive Board
• H. Bryan Brewer, Jr.

About Us

H. Bryan Brewer, Jr.

• 1Scientific Training (1 page)
• 2Current and Past Positions (1 page)
• 3Publications and Book Chapters (1 page)
• 4Awards and Distinctions (1 page)
• 5Professional Associations (1 page)
• 6Additional Information (1 page)

Additional Information

Page: 6 of 6

---

Editorial Boards
American Journal of Cardiology, 1983-1985
Journal of Lipid Research, Associate Editor, 1982-1987
Journal of Biological Chemistry, 2001-2006
Journal of Clinical Lipidology, Associate Editor, 2006 to present

Dr. Brewer’s research interests include atherosclerosis, hyperlipidemia, and identifying the gene defects that lead to genetic dyslipoproteinemias, clinical trials for HDL therapy.

---

Page: 6 of 6

Print this document

• H. Bryan Brewer, Jr.

See this member in the flowchart

• Contact Us
• Site Map
• Links
• Our Partners
• Press Room
• Legal Notices

© 2012, International Chair on Cardiometabolic Risk